Business
HumanisRx signs agreement with The North West Company to provide Proactive Medication Optimization
HumanisRx signs agreement with The North West Company to provide Proactive Medication Opt...
About this update from North West Company Inc.
[{"type":"text","content":"\n \n \n \n HumanisRx signs agreement with The North West Company to provide Proactive Medication Optimization\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n MARKHAM, ON, Dec. 1, 2020\n \n \n \n \n \n MARKHAM, ON\n \n ,\n \n Dec. 1, 2020\n \n /CNW/ - HumanisRx today announced it has entered into an agreement to provide medication optimization services to The North West Company (TSX: NWC) by leveraging its MedMonitor program. MedMonitor is a unique Canadian program applying RxCompanion™ software to run clinical algorithms against prescription data to identify risks related to a patient's medication therapy.  Patients who are provided health and pharmacy services by NWC will be referred directly to the MedMonitor program.\n \n \n NWC provides high quality and vital healthcare services in remote locations in a large geographical region in\n \n Northern Canada\n \n .  The distance these patients must travel for healthcare makes monitoring and follow-up for disease management difficult, leading to a pressing need for improved primary care in remote northern communities. Utilizing MedMonitor, NWC aims to identify patients with more urgent need of healthcare services to address their issues earlier before their conditions escalate and require more severe and costly intervention.\n \n \n Earlier this year, NWC engaged HumanisRx to conduct a study on 9,000 of its patients using RxCompanion™ software.  The study found:\n \n \n \n One in every 2.5 patients had at least one drug therapy problem.\n \n \n Drug therapy problems related to mental health were identified most often followed by diabetes and cardiovascular disease.\n \n \n 16% of patients had multiple drug therapy problems, carrying a higher risk of health issues leading to increased morbidity and healthcare costs.\n \n \n \n \"We are very excited to have partnered with HumanisRx in an effort to further enhance patient care utilizing their population-level monitoring tool that identifies patients at risk of poor health outcomes.\" states\n \n Laurie Kami...